← Back to Search

Nature Walks for Breast Cancer Survivors

N/A
Waitlist Available
Led By Arash Asher, M.D.
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Minimum of 3 months post-active treatment completion
Previously diagnosed with cancer
Must not have
Known metastatic disease.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether nature-based activities provide benefits for breast cancer survivors and whether the program is feasible.

Who is the study for?
This trial is for women over 39 who had breast cancer (stages 1-3) and finished treatment at least 3 months ago, can walk without help, and are not currently very active. A sub-study includes men and women aged 18-39 who've had any type of cancer and completed treatment up to 21 months prior.
What is being tested?
The study tests if nature-based exercises benefit those who have survived breast cancer. It involves physical activities in a natural setting. The main study will include up to 20 women with past breast cancer, while the sub-study will enroll up to 20 younger adults with any past cancer diagnosis.
What are the potential side effects?
Since this intervention involves exercise, potential side effects may include muscle soreness, fatigue or minor injuries related to physical activity. However, these activities are generally considered safe and beneficial for most participants.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I finished my cancer treatment at least 3 months ago.
Select...
I have been diagnosed with cancer before.
Select...
I am 40 years old or older.
Select...
I can walk by myself without help.
Select...
I am a woman who was diagnosed with early to locally advanced breast cancer.
Select...
I am between 18 and 39 years old.
Select...
I am under 18 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My cancer has spread to other parts of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants that adhere to a 3-month nature-based walking program
Secondary study objectives
Anti-inflammatory cytokine
Biologic aging markers
IL-13 cytokine
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ActiveExperimental Treatment1 Intervention
Participants will be asked to complete a 12 week exercise program

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
512 Previous Clinical Trials
163,344 Total Patients Enrolled
3 Trials studying Lymphoma
42 Patients Enrolled for Lymphoma
Arash Asher, M.D.Principal InvestigatorCedars-Sinai Medical Center
Celina Shirazipour, PhDPrincipal Investigator - Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
1 Previous Clinical Trials
12 Total Patients Enrolled

Media Library

Nature based exercise Clinical Trial Eligibility Overview. Trial Name: NCT04896580 — N/A
Lymphoma Research Study Groups: Active
Lymphoma Clinical Trial 2023: Nature based exercise Highlights & Side Effects. Trial Name: NCT04896580 — N/A
Nature based exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT04896580 — N/A
~5 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top